We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ANR market cap is 6.55M. The company's latest EPS is AUD -0.0120 and P/E is -3.33.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.54M | 790k | 1.11M | 487k | 1.25M |
| Operating Income | -3.01M | -3.42M | -1.97M | -2.54M | -2.04M |
| Net Income | -2.87M | -3.37M | -2M | -2.53M | -2.02M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 6.38M | 3.34M | 4.33M | 1.77M | 1.42M |
| Total Liabilities | 467k | 487k | 497k | 404k | 494k |
| Total Equity | 5.92M | 2.86M | 3.83M | 1.36M | 925k |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.43M | -2.73M | -2.1M | -2.23M | -2.26M |
| Investing | 2.34M | 4.05M | -4k | -56k | -2k |
| Financing | N/A | N/A | 2.85M | -24k | 1.49M |
| Market Cap | 6.55M |
| Price to Earnings Ratio | -3.33 |
| Price to Sales Ratio | 5.41 |
| Price to Cash Ratio | 19.05 |
| Price to Book Ratio | 7.26 |
| Dividend Yield | - |
| Shares Outstanding | 167.89M |
| Average Volume (1 week) | 175.31k |
| Average Volume (1 Month) | 267.2k |
| 52 Week Change | 34.48% |
| 52 Week High | 0.052 |
| 52 Week Low | 0.021 |
| Spread (Intraday) | 0.01 (14.29%) |
| Company Name | Antara Lifesciences Ltd |
| Address |
level 8, 81 flinders street adelaide, south australia 5000 |
| Website | https://anataralifesciences.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
